Metabolic precursors of hypertension. The San Antonio Heart Study

Archives of Internal Medicine

Volumn 156, Issue 17, 1996, Pages 1994-2000

  Haffner, Steven M ^a   Miettinen, Heikki ^a   Gaskill, Sharon P ^a   Stern, Michael P ^a  

^a Mays Cancer Center at UT Health San Antonio   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

INSULIN;

ADULT; ARTICLE; BODY MASS; DISEASE CONTROL; ETHNOLOGY; HUMAN; HYPERTENSION; INSULIN BLOOD LEVEL; INSULIN RESISTANCE; MAJOR CLINICAL STUDY; OBESITY; PREDICTION; PRIORITY JOURNAL; PROGNOSIS; RISK ASSESSMENT; RISK FACTOR; SEX DIFFERENCE;

ADULT; ANTHROPOMETRY; BLOOD GLUCOSE; EUROPEAN CONTINENTAL ANCESTRY GROUP; FASTING; FEMALE; FOLLOW-UP STUDIES; HUMANS; HYPERLIPIDEMIAS; HYPERTENSION; INCIDENCE; INSULIN; MALE; MEXICAN AMERICANS; MIDDLE AGED; OBESITY; PROSPECTIVE STUDIES; TEXAS;

EID: 0029797001     PISSN: 00039926     EISSN: None     Source Type: Journal    
DOI: 10.1001/archinte.156.17.1994     Document Type: Article

References (76)

1. Klatsky AL, Friedman GD, Siegelaub AB, Gerard MJ. Alcohol consumption and blood pressure: Kaiser-Permanente Multiphasic Health Examination data. N Engl J Med. 1977;296:1194-1200.
2. Wilkins SVB, Berlanger A, Kannel WB, D'Agostino RB, Steel K. Determinants of isolated systolic hypertension. JAMA. 1988;260:3451-3455.
3. Garrison RJ, Kannel WB, Stokes J, Castelli WP. Incidence and precursors of hypertension in young adults: the Framingham Offspring Study. Prev Med. 1987; 16:235-251.
4. Dyer AR, Stamler J, Shekelle RB, et al. Relative weight and blood pressure in four Chicago epidemiologic studies. J Chron Dis. 1982;35:897-908.
5. Niskanen LK, Uusitupa MI, Pyörälä K. The relationship of hyperinsulinemia to the development of hypertension in type 2 diabetic patients and in nondiabetic subjects. J Hum Hypeitens. 1991;5:155-159.
6. Skarfors ET, Lithell HO, Selinus I. Risk factors for the development of hypertension: a 10-year longitudinal study in middle-aged men. J Hypertens. 1991; 9:217-223.
7. Lissner L, Bengtsson C, Lapidus L, Kristjansson K, Wedel H. Fasting insulin in relation to subsequent blood pressure changes and hypertension in women. Hypertension. 1992;20:797-801.
8. Haffner SM, Ferrannini E, Hazuda HP, Stern MP. Clustering of cardiovascular risk factors in confirmed prehypertensive individuals. Hypertension. 1992;20: 38-45.
9. Shetterly SM, Rewers M, Hamman RF, Marshall JA. Patterns and predictors of hypertension incidence among Hispanics and non-Hispanic whites: the San Luis Valley Diabetes Study. J Hypertens. 1994;12:1095-1102.
10. Feskens EM, Tuomiletito J, Stengard JH, Pekkanen J, Nissinen A, Kromhout D. Hypertension and overweight associated with hyperinsulinemia and glucose tolerance: a longitudinal study of the Finnish and Dutch cohorts of the Seven Countries Study. Diabetologia. 1995;39:839-847.
11. Modan M, Halkin H, Almog S, et al. Myperinsulinemia: a link between hypertension, obesity and glucose intolerance. J Clin Invest. 1985;75:809-817.
12. Webber LS, Voors AW, Srinivasan SR, Frerichs RR, Berenson GS. Occurrence in children of multiple risk factors for coronary artery disease: the Bogalusa Heart Study. Prev Med. 1979;8:407-418.
13. Zavaroni I, Bonora E, Pagliara M, et al. Risk factors for coronary artery disease in healthy persons with hyperinsulinemia and normal glucose tolerance. N Engl J Med. 1989;320:702-706.
14. Orchard TJ, Becker DJ, Bates M, Kuller LH, Drash AL. Plasma insulin and lipoprotein concentrations: an atherogenic association? Am J Epidemiol. 1983; 118:326-337.
15. Haffner SM, Fong D, Hazuda HP, Pugh JA, Palterson JK. Hyperinsulinsmia, upper body adiposity and cardiovascular risk factors in nondiabetics. Metabolism. 1988;37:338-345.
16. Williams RR, Hunt SC, Hopkins PN, et al. Familial dyslipidemia hypertension: evidence from 58 Utah families for a syndrome present in approximately 12% of patients with essential hypertension. JAMA. 1988;259:3579-3586.
17. Hunt SC, Wu LL, Hopkins PN, et al. Apolipoprotein, low-density lipoprotein subfraction, and insulin associations with familial combined hyperlipidemia: study of Utah patients with familial dyslipidemic hypertension. Arteriosclerosis. 1989;9:335-344.
18. DeFronzo RA, Ferrannini E. Insulin resistance: a multitaceted syndrome responsible for NIDDM, obesity, hypertension, dyslipidemia and atherosclerotic cardiovascular disease. Diabetes Care. 1991;14:173-194.
19. Haffner SM. Insulin and blood pressure: fact or fantasy? J Clin Endocrinol Metab. 1992;76:541-543.
20. Ferrannini E, Buzzigoli G, Bonadonna R, et al. Insulin resistance in essential hypertension. N Engl J Med. 1987;317:350-357.
21. Pollare T, Lithell H, Berne C. Insulin resistance is a characteristic feature of primary hypertension independent of obesity. Metabolism. 1990;39:167-174.
22. Reaven GM. Role of insulin resistance in human disease: Banting Lecture 1988. Diabetes. 1988;37:1595-1607.
23. Kaplan MM. The deadly quartet: upper body adiposity, glucose intolerance, hypertriglyceridemia and hypertension. Arch Intern Med. 1989;149:1514-1520.
24. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Bennett PH. Insulin and hypertension: relationship to obesity and glucose intolerance in Pima Indians. Diabetes. 1990;39:1430-1435.
25. Cambien F, Warnet JM, Eschwege E, Jacqueson A, Richard JL, Rosselin G. Body mass, blood pressure, glucose and lipids: does plasma insulin explain their relationships? Arteriosclerosis. 1987;7:197-202.
26. Mbanya JC, Thomas TH, Wilkinson R, Alberti KG, Taylor R. Hypertension and hyperinsulinemia: a relationship in diabetes but not in essential hypertension. Lancet. 1988;1:733-734.
27. Laakso M, Sarlund K, Mykkänen L. Essential hypertension and insulin resistance in non-insulin-dependent diabetes. Eur J Clin Invest. 1989;19:518-526.
28. Saad MF, Lillioja S, Nyomba BL, et al. Racial differences in the relation between blood pressure and insulin resistance. N Engl J Med. 1991;324: 733-739.
29. Falkner B, Hulman D, Tannenbaum J, Kushner H. Insulin resistance and blood pressure in young black men. Hypertension. 1990;16.706-711.
30. Lillioja S, Mott DM, Spraul M, et al. Insulin resistance and insulin secretory dysfunction as precursors of non-insulin-dependent diabetes mellitus: prospective studies of Pima Indians. N Engl J Med. 1993;329:1988-1992.
31. Warram JH, Martin BC, Krolewski AS, Soeldner JS, Kahn CR. Slow glucose removal rate and hyperinsulinemia precede the development of type II diabetes in the offspring of diabetic patients. Ann Intern Med. 1990;113:909-915.
32. Sicree RA, Zimmet PZ, King HO, Coventry JS. Plasma insulin response among Nauruans: prediction of deterioration in glucose tolerance over 6 years. Diabetes. 1987;36:179-186.
33. Haffner SM, Stern MP, Mitchell BD, Hazuda HP, Patterson JK. Incidence of type II diabetes in Mexican Americans predicted by fasting insulin and glucose levels, obesity and body fat distribution. Diabetes. 1990;39:283-288.
34. Bergstrom RW, Newell-Morris LL, Leonetti DL, Shuman WP, Wahl PW, Fujimoto WY. Association of elevated fasting C-peptide level and increased intraabdominal fat distribution with development of NIDDM in Japanese American men. Diabetes. 1990;39:104-111.
35. Charles MA, Fontbonne A, Thibult N, Warnet JM, Rosselin GE, Eschwege R. Risk factors for NIDDM in white populations: Paris Prospective Study. Diabetes. 1991;40:796-799.
36. Mykkänen L, Kuusisto J, Pyörälä K, Laakso M. Cardiovascular disease risk factors as predictors of type II (non-insulin-dependent) diabetes mellitus in elderly subjects. Diabetologia. 1993;36:553-559.
37. Saad MF, Knowler WC, Pettitt DJ, Nelson RG, Mott DM, Benntt PH. The natural history of impaired glucose tolerance in the Pima Indians. N Engl J Med. 1988;319:1500-1506.
38. Haffner SM, Miettinen H, Gaskill SP, Stern MP. Decreased insulin secretion and increased insulin resistance are independently related to the seven-year risk of non-insulin-dependent diabetes mellitus in Mexican Americans. Diabetes. 1995;44:1386-1391.
39. Lundgren H, Bengtsson C, Blohme G, Lapidus L, Waldenström J. Fasting serum insulin concentrations and early response as risk determinants for developing diabetes. Diabet Med. 1990;7:407-413.
40. Efendic S, Luft R, Wajngot A. Aspects of the pathogenesis of type 2 diabetes. Endocr Rev. 1984;5:395-410.
41. Kosaka K, Hagura R, Kuzuya T. Insulin responses in equivocal and definite diabetes with special reference to subjects who had mild glucose intolerance but later developed definite diabetes. Diabetes. 1977;26:944-952.
42. Kadowaki T, Miyake Y, Hagura R, et al. Risk factors for worsening to diabetes in subjects with impaired glucose tolerance. Diabetologia. 1984;26:44-49.
43. Porte D. Banting lecture 1990. β Cells in type II diabetes mellitus. Diabetes. 1991;40:166-180.
44. Philips DI, Clark PM, Hales CN, Osmond C. Understanding oral glucose tolerance: comparison of glucose and insulin measurements during the oral glucose tolerance test with specific measurements of insulin resistance and insulin secretion. Diabet Med. 1994;11:286-292.
45. Nagi DK, Hendra TJ, Ryle AJ, et al. The relationship of concentrations of insulin, intact proinsulin, and 32-33 split proinsulin with cardiovascular risk factors in type II (non-insulin-dependent) diabetic subjects. Diabetologia. 1990; 33:532-537.
46. Haffner SM, Mykkänen L, Stern MP, Valdez RA, Heisserman JA, Bowsher RR. Relationship of proinsulin and insulin to cardiovascular risk factors in nondiabetic subjects. Diabetes. 1993;92:1297-1302.
47. Stern MP, Rosenthal M, Haffner SM, Hazuda HP, Franco U. Sex differences in the effects of sociocultural status on diabetes and cardiovascular risk factors in Mexican Americans: the San Antonio Heart Study. Am J Epidemiol. 1984; 120:834-851.
48. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK. Hyperinsulinemia in a population at high risk for non-insulin-dependent diabetes mellitus. N Engl J Med. 1986;315:220-224.
49. Hazuda HP, Comeaux PJ, Stern MP, Haffner SM, Eifler CW, Rosenthal M. A comparison of three indicators for identifying Mexican Americans in epidemiologic research: methodological findings from the San Antonio Heart Study. Am J Epidemiol. 1986;123:96-112.
50. Haffner SM, Hazuda HP, Mitchell BD, Patterson JK, Stern MP. Increased incidence of type II diabetes mellitus in Mexican Americans. Diabetes Care. 1991; 14:102-108.
51. Haffner SM, Stern MP, Hazuda HP, Pugh JA, Patterson JK, Malina R. Upper body and centralized adiposity in Mexican Americans and non-Hispanic whites: relationship to body mass index and other behavioral and demographic variables. Int J Obes Relat Metab Disord. 1986;10:493-502.
52. Hypertension Detection and Follow-up Program Cooperative Group. The Hypertension Detection and Follow-up Program. Prev Med. 1976;5:207-215.
53. Haffner SM, Bowsher RR, Mykkänen L, et al. Proinsulin and specific insulin concentration in high- and low-risk populations for non-insulin-dependent diabetes mellitus. Diabetes. 1994;43:1490-1493.
54. World Health Organization Expert Committee on Diabetes Mellitus. Second Report. Geneva, Switzerland: World Health Organization; 1985. Technical Report Series 727.
55. Hollenbeck CB, Chen N, Chen YD, Reaven GM. Relationship between the plasma insulin response to oral glucose and insulin-stimulated glucose utilization in normal subjects. Diabetes. 1984;33:460-463.
56. Saad MF, Anderson RL, Laws A, et al, for the Insulin Resistance Atherosclerosis Study. A comparison between the minimal model and the glucose clamp in the assessment of insulin sensitivity across the spectrum of glucose tolerance. Diabetes. 1994;43:1114-1121.
57. Kahn SE, Prigeon RL, McCulloch DK, et al. Quantification of the relationship between insulin sensitivity and β-cell function in human subjects: evidence for a hyperbolic function. Diabetes. 1993;42:1663-1672.
58. Swislocki ALM, Hoffman BB, Reaven GM. Insulin resistance, glucose intolerance and hyperinsulinemia in patients with hypertension. Am J Hypertens. 1969; 2:419-423.
59. Bonora E, Moghetti P, Zenere M, Tosi F, Travia D, Muggeo M. β-Cell secretion and insulin sensitivity in hypertensive and normotensive obese subjects. Int J Obes Relat Metab Disord. 1990;14:735-742.
60. Saad MF, Howard G, Rewers M, Mykkänen L, Bergman RN, Savage PJ. Insulin resistance but not insulinemia is associated with hypertension: the Insulin Resistance Atherosclerosis Study. Circulation. 1994;89:934. Abstract.
61. Temple RC, Carringlon CA, Luzio SD, et al. Insulin deficiency in non-insulin-dependent diabetes. Lancet. 1989;1:293-295.
62. Reaven GM, Chen YD, Hollenbeck CB, Sheu WH, Ostrega D, Polonsky KS. Plasma insulin, C peptide and proinsulin concentrations In obese and nonobese individuals with varying degrees of glucose tolerance. J Clin Endocrinol Metad. 1993;76:44-48.
63. Yoshioka N, Kuzuya T, Matsuda A, Taniguchi M, Iwamoto Y. Serum proinsulin levels at fasting and after oral glucose load in patients with type II (non-insulin-dependent) diabetes mellitus. Diabetologia. 1938;31:355-360.
64. Saad MF, Kahn SE, Nelson RG, et al. Disproportionately elevated proinsulin in Pima Indians with non-insulin-dependent diabetes mellitus. J Clin Endocrinol Metab. 1990;70:1247-1253.
65. Haffner SM, Mykkänen L, Valdez RA, Stem MP. Evaluation of two insulin assays in insulin resistance syndrome (syndrome X). Arterioscler Thromb Vasc Biol. 1994;14:1430-1437.
66. Rowe JW, Young JB, Minaker KL, Stevens AL, Pallotta J, Landsberg L. Effect of insulin and glucose infusions on sympathetic nervous system in normal men. Diabetes. 1981;30:219-225.
67. Stout RW, Bierman EL, Ross R. Effect of insulin on the proliferation of cultured primate arterial smooth muscle cells. Circ Res. 1975;36:319-327.
68. Moore RD. Effects of insulin upon ion transport. Biochim Biophys Acta. 1983; 737:1-49.
69. DeFronzo RA. The effect of insulin on renal sodium metabolism: a review with clinical implications. Diabetologia. 1981;21:165-171.
70. Laakso M, Edelman SV, Brechtel G, Baron AD. Decreased effect of Insulin to stimulate skeletal muscle blood flow in obese men: a novel mechanism for insulin resistance. J Clin Invest. 1990;85:1844-1852.
71. Hall JE, Coleman TG, Mizelle HL, Smith MJ. Chronic hyperinsulinemia and blood pressure regulation. Am J Physiol. 1990;258(suppl F):722-731.
72. Anderson EA, Hoffman RP, Balon TW, Sinkey CA, Mark AL. Hyperinsulinemia produces both sympathetic neural activation and vasodilation in normal humans. J Clin Invest. 1991;87:2246-2252.
73. Brands MW, Hildebrandt DA, Mizelle HL, Hall JE. Sustained hyperinsulinemia increases arterial pressure in conscious rats. Am J Physiol. 1991;260(suppl R):764-768.
74. Stern MP, Morales PA, Haffner SM, Valdez RA. Hyperdynamic circulation and the insulin resistance syndrome ('syndrome X'). Hypertension. 1992;20:802-808.
75. Robbins DC, Andersen L, Bowsher R, et al. Report of the American Diabetes Association Task Force on standardization of the insulin assay. Diabetes. 1996; 45:242-256.
76. Haffner SM. Risk factors for non-insulin-dependent diabetes mellitus. J Hypertens. 1995;13(suppl 2):575-576.